Treace Medical Concepts Reports Third-Quarter 2026 Financial Results
Treace Medical Concepts said procedure volume grew by double digits in the third quarter.
Story updates
12:07:00 PM UTC
SquawkNews
Q3 2026 revenue was $48.3M, down 4% from $50.2M a year earlier; net loss narrowed to $12.6M from $16.3M. Treace narrowed its expected 2026 Adjusted EBITDA loss to $1.0M—$2.0M from $3.0M—$5.0M.Material DetailsContext by AI AnalystThis is a mixed quarterly update: revenue declined, while losses and c…
Achieved double digit procedure volume growth in the third quarterPONTE VEDRA, Fla., Nov. 06, 2026 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. ("Treace" or the "Company") NasdaqGS:TMCI, a medical technology company with the goal of being the recognized leader in the surgical treatment of buni…